# Redwood Trust Inc: financial statements, quarterly

RWT · NYSE · CIK 930236 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rwt.md) · [Financials](/companies/rwt/financials.md) · [Filings](/companies/rwt/filings.md) · [Insiders](/companies/rwt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rwt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [157](/filings/0000930236-23-000038.md) | [170 d](/filings/0000930236-24-000009.md) | [181](/filings/0000930236-24-000023.md) | [200](/filings/0000930236-24-000031.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.7](/filings/0000930236-24-000038.md) | [1.0 d](/filings/0000930236-26-000007.md) | [0.5](/filings/0000930236-25-000020.md) | [4.9](/filings/0000930236-25-000029.md) | [7.1](/filings/0000930236-25-000037.md) | [6.3 d](/filings/0000930236-26-000007.md) | [6.3](/filings/0000930236-26-000020.md) | [4.6](/filings/0000930236-26-000027.md) | [6.4](/filings/0000930236-25-000037.md) | [8.0 d](/filings/0000930236-26-000007.md) | [(2.5)](/filings/0000930236-26-000020.md) | [1.1](/filings/0000930236-26-000027.md) |
| Net income | $m | [(30.8)](/filings/0000930236-24-000038.md) | [21.0 d](/filings/0000930236-26-000007.md) | [30.3](/filings/0000930236-25-000020.md) | [15.5](/filings/0000930236-25-000029.md) | [14.8](/filings/0000930236-25-000037.md) | [(6.6) d](/filings/0000930236-26-000007.md) | [16.1](/filings/0000930236-26-000020.md) | [(98.5)](/filings/0000930236-26-000027.md) | [(7.7)](/filings/0000930236-25-000037.md) | [20.0 d](/filings/0000930236-26-000007.md) | [(5.5)](/filings/0000930236-26-000020.md) | [(1.1)](/filings/0000930236-26-000027.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0000930236-24-000038.md) | not reported | [0.21](/filings/0000930236-25-000020.md) | [0.10](/filings/0000930236-25-000029.md) | [0.09](/filings/0000930236-25-000037.md) | not reported | [0.10](/filings/0000930236-26-000020.md) | [(0.76)](/filings/0000930236-26-000027.md) | [(0.08)](/filings/0000930236-25-000037.md) | not reported | [(0.07)](/filings/0000930236-26-000020.md) | [(0.03)](/filings/0000930236-26-000027.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0000930236-24-000038.md) | not reported | [0.21](/filings/0000930236-25-000020.md) | [0.10](/filings/0000930236-25-000029.md) | [0.09](/filings/0000930236-25-000037.md) | not reported | [0.10](/filings/0000930236-26-000020.md) | [(0.76)](/filings/0000930236-26-000027.md) | [(0.08)](/filings/0000930236-25-000037.md) | not reported | [(0.07)](/filings/0000930236-26-000020.md) | [(0.03)](/filings/0000930236-26-000027.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0000930236-24-000038.md) | [0.3](/filings/0000930236-26-000007.md) | [0.3](/filings/0000930236-25-000020.md) | [0.3](/filings/0000930236-25-000029.md) | [0.3](/filings/0000930236-25-000037.md) | [0.2](/filings/0000930236-26-000007.md) | [0.3](/filings/0000930236-26-000020.md) | [0.3](/filings/0000930236-26-000027.md) | [0.2](/filings/0000930236-25-000037.md) | [0.3](/filings/0000930236-26-000027.md) | [0.2](/filings/0000930236-26-000020.md) | [0.2](/filings/0000930236-26-000027.md) |
| Total assets | $bn | [13.0](/filings/0000930236-24-000038.md) | [14.5](/filings/0000930236-26-000007.md) | [15.1](/filings/0000930236-25-000020.md) | [16.5](/filings/0000930236-25-000029.md) | [18.4](/filings/0000930236-25-000037.md) | [18.3](/filings/0000930236-26-000007.md) | [19.9](/filings/0000930236-26-000020.md) | [21.3](/filings/0000930236-26-000027.md) | [22.6](/filings/0000930236-25-000037.md) | [23.7](/filings/0000930236-26-000027.md) | [26.8](/filings/0000930236-26-000020.md) | [28.8](/filings/0000930236-26-000027.md) |
| Total liabilities | $bn | [11.9](/filings/0000930236-23-000038.md) | [13.3](/filings/0000930236-25-000007.md) | [13.8](/filings/0000930236-24-000023.md) | [15.3](/filings/0000930236-24-000031.md) | [17.2](/filings/0000930236-24-000038.md) | [17.1](/filings/0000930236-26-000007.md) | [18.7](/filings/0000930236-25-000020.md) | [20.3](/filings/0000930236-25-000029.md) | [21.6](/filings/0000930236-25-000037.md) | [22.7](/filings/0000930236-26-000027.md) | [25.9](/filings/0000930236-26-000020.md) | [27.9](/filings/0000930236-26-000027.md) |
| Long-term debt | $bn | [1.8](/filings/0000930236-23-000038.md) | [1.7](/filings/0000930236-24-000023.md) | [1.7](/filings/0000930236-24-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | [1.5](/filings/0000930236-23-000038.md) | [1.6](/filings/0000930236-24-000023.md) | [1.3](/filings/0000930236-24-000023.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [1.1](/filings/0000930236-24-000038.md) | [1.2](/filings/0000930236-26-000007.md) | [1.2](/filings/0000930236-25-000029.md) | [1.2](/filings/0000930236-25-000037.md) | [1.2](/filings/0000930236-25-000037.md) | [1.2](/filings/0000930236-26-000027.md) | [1.2](/filings/0000930236-26-000027.md) | [1.1](/filings/0000930236-26-000027.md) | [1.0](/filings/0000930236-25-000037.md) | [1.0](/filings/0000930236-26-000027.md) | [1.0](/filings/0000930236-26-000027.md) | [0.9](/filings/0000930236-26-000027.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(891) d](/filings/0000930236-24-000038.md) | [(1,148) d](/filings/0000930236-26-000007.md) | [(954)](/filings/0000930236-25-000020.md) | [(1,966) d](/filings/0000930236-25-000029.md) | [(2,088) d](/filings/0000930236-25-000037.md) | [(854) d](/filings/0000930236-26-000007.md) | [(1,953)](/filings/0000930236-26-000020.md) | [(2,113) d](/filings/0000930236-26-000027.md) | [(2,668) d](/filings/0000930236-25-000037.md) | [(3,361) d](/filings/0000930236-26-000007.md) | [(4,508)](/filings/0000930236-26-000020.md) | [(3,747) d](/filings/0000930236-26-000027.md) |
| Dividends paid | $m | [19.7 d](/filings/0000930236-24-000038.md) | [21.9 d](/filings/0000930236-26-000007.md) | [22.1](/filings/0000930236-25-000020.md) | [22.1 d](/filings/0000930236-25-000029.md) | [23.6 d](/filings/0000930236-25-000037.md) | [25.1 d](/filings/0000930236-26-000007.md) | [25.4](/filings/0000930236-26-000020.md) | [25.3 d](/filings/0000930236-26-000027.md) | [24.3 d](/filings/0000930236-25-000037.md) | [24.0 d](/filings/0000930236-26-000007.md) | [23.8](/filings/0000930236-26-000020.md) | [24.1 d](/filings/0000930236-26-000027.md) |
| Share repurchases | $m | [0.0 d](/filings/0000930236-23-000038.md) | [0.0 d](/filings/0000930236-26-000007.md) | not reported | not reported | [0.0 d](/filings/0000930236-25-000037.md) | [0.0 d](/filings/0000930236-26-000007.md) | [0.0](/filings/0000930236-26-000020.md) | [7.5 d](/filings/0000930236-26-000027.md) | [29.6 d](/filings/0000930236-25-000037.md) | [14.8 d](/filings/0000930236-26-000007.md) | [1.1](/filings/0000930236-26-000020.md) | [0.0 d](/filings/0000930236-26-000027.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [116](/filings/0000930236-23-000038.md) | [114](/filings/0000930236-24-000023.md) | [114](/filings/0000930236-24-000031.md) | [115](/filings/0000930236-24-000038.md) | [132](/filings/0000930236-25-000020.md) | [132](/filings/0000930236-25-000029.md) | [132](/filings/0000930236-25-000037.md) | [133](/filings/0000930236-26-000020.md) | [133](/filings/0000930236-26-000027.md) | [129](/filings/0000930236-25-000037.md) | [125](/filings/0000930236-26-000020.md) | [125](/filings/0000930236-26-000027.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 125,612,432 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0000930236-26-000027.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.